Evidence map›Paper›PMID 32161503›Full record

ArticleClinical epidemiology2020

Incidence Rate of Advanced Chronic Kidney Disease Among Privately Insured Adults with Neurodevelopmental Disabilities.

Daniel G Whitney, Mary Schmidt, Sarah Bell, Hal Morgenstern, Richard A Hirth

Abstract read
In one paragraph

Article in Clinical epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Readmission and Mortality After Hospitalization With Acute Kidney Injury.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Multi-Organ Dysfunction in Cerebral Palsy.Frontiers in pediatrics · 2021
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel G WhitneyDepartment of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Mary SchmidtDepartment of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Sarah BellDepartment of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Hal MorgensternDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Richard A HirthInstitute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-0654-3220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDue to complex medical profiles, adults with neurodevelopmental disabilities (NDDs) may have a heightened risk for early development of chronic kidney disease (CKD) and accelerated CKD progression to advanced stages and kidney failure. The purpose of this study was to estimate the incidence rate of advanced CKD for adults with NDDs and compare the incidence rate to adults without NDDs. PATIENTS AND

methodsData were used from the Optum Clinformatics

resultsAdults with NDDs (n=33,561) had greater crude IR of advanced CKD (IRR=1.32; 95% CI=1.24-1.42) compared to adults without NDDs (n=6.5M). The elevated rate of advanced CKD among adults with NDDs increased after adjusting for demographics (HR=2.19; 95% CI=2.04-2.34) and remained elevated with further adjustment for hypertension and diabetes (HR=2.01; 95% CI=1.87-2.15) plus cardiovascular disease (HR=1.84; 95% CI=1.72-1.97). Stratified analyses showed that the risk of advanced CKD was greater for all NDD subgroups.

conclusionStudy findings suggest that adults with NDDs have a greater risk of advanced CKD than do adults without NDDs, and that difference is not explained by covariates used in our analysis.

Indexed as

autism spectrum disorderscerebral palsychronic kidney diseaseintellectual disabilitiesneurodevelopmental disabilities

Identifiers

PMID32161503
PMCPMC7051893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.